Prosecution Insights
Last updated: April 19, 2026

Ip2Ipo Innovations Limited

7 pending office actions

Portfolio Summary

7
Total Pending OAs
2
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18921693 Implant System BLANCO, JAVIER G 3774 Final Rejection Oct 21, 2024
18817094 Rhinovirus Vaccine SIFFORD, JEFFREY MARK 1671 Non-Final OA Aug 27, 2024
18028498 ZIP12 ANTIBODY LI, RUIXIANG 1674 Non-Final OA Mar 24, 2023
18001317 4-ETHYNYLPYRIDINE DERIVATIVES USEFUL AS GCN2 INHIBITORS LEE, ANDREW P 1691 Non-Final OA Dec 09, 2022
17614374 BIOMARKER DETECTION FOR CANCER DIAGNOSIS AND PROGNOSIS ALABI, OYELEYE A 1797 Non-Final OA Nov 26, 2021
17430639 METHOD FOR DIAGNOSING OESOPHAGOGASTRIC CANCER HUANG, MICKEY NMN 1758 Non-Final OA Aug 12, 2021
17297792 REDOX FLOW BATTERY LEE, JAMES 1725 Final Rejection May 27, 2021

Managing Ip2Ipo Innovations Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month